Knowledge and Attitudes Toward Genetic Testing in Parkinson’s Disease Dana Lundberg 2006

Knowledge and Attitudes Toward Genetic Testing in

Parkinson’s Disease

Dana Lundberg 2006

• Is a degenerative neurological disorder

• Affects the substantia nigra, the part of the brain that controls movement

• Includes three symptoms: a resting tremorrigiditybradykinesia (slowness)

Substantia Nigrawww.nlm.nih.gov/medlineplus/

ency/imagepages/19515.htm

• Parkinson’s disease is divided into two onset categories:

Young-onset (less than 50 years at onset)Old-onset (50 years or older at onset)

Onset Categories

Objectives

• To identify attitudes Parkinson’s disease patients have toward diagnostic, predictive, and prenatal genetic testing

• To identify the resources most used by patients for information on Parkinson’s disease

• To assess the level of knowledge patients have about the genetics of Parkinson’s disease

Genetics of Parkinson’s • Studies by Healy et al. (2004), Toft et al. (2005), and

Hattori et al. (2004) revealed several gene mutations

• Genes that mutations have been identified in:- parkin- PINK1- DJ-1- α-Synuclein- LRKK2

• Clinical genetic testing for the parkin and PINK1 genes is available

Rationale•Prior to wide spread use of genetic testing for Parkinson’s

disease researchers need to be aware of:

The interest level in genetic testing

The level of knowledge patients have of genetic testing

Where to target educational programs for genetic testing

• Jacobs et al. showed attitudes toward genetic testing in a young-onset Parkinson’s population:

72% of subjects indicated that they would take a presymptomatic genetic test

57% were interested in the availability of a prenatal genetic test for Parkinson’s

• My study differs:It included both young and old-onset patientsIt included questions regarding sources of information and

knowledge about the genetics of Parkinson’s

Background

Hypothesis

Patients with Parkinson’s disease will respond with a positive attitude toward diagnostic, predictive, and prenatal genetic testing for the disease.

• Struthers Parkinson’s Center (n = 58)• National Parkinson Foundation’s Young-Onset Conference

in Phoenix, AZ (n = 39)

Struthers Parkinson’s Center (Golden Valley, MN)

Young-Onset Parkinson’s Conference (Phoenix, AZ)

Survey Sites

Survey• Demographics• General knowledge about:

Parkinson’s disease genetics genetics of Parkinson’s disease

• Sources of information on Parkinson’s disease• Attitudes toward:

diagnostic genetic testing predictive genetic testing prenatal genetic testing genetic testing at 100%, 90%, and 60% genetic risk

Data Analysis• Data were tabulated in an Excel spreadsheet• Data were analyzed using descriptive and nonlinear

(chi-squared) statistics • P-values were considered significant when p ≤ 0.050

Distribution of Age of Onset

onset < 50 years

onset ≥ 50 years47%53%

Distribution of Gender

MaleFemale

58%42%

Education Levels of Subject Population

High school

Technical training orsome collegeCollege graduate orhigher

16%65%

Distribution of Subjects with Relatives Diagnosed with

Parkinson’s

none≥ 1

Neurologist

Books/ magazinesLay organizations

Support/ Conference/Edu. programs

InternetNurse

Physical/

Occupational/Speech

Friends/Family

Radio/TV

Primary Care DoctorSources

Number of subjects

< 50 years at onset

≥ 50 years at onset

Sources of InformationP<0.001

Neurologist

InternetNurse

Physical/

Occupational/Speech

Friends/Family

Radio/TV

Number of subjects

< 50 years at onset

Neurologist

InternetNurse

Physical/

Occupational/Speech

Friends/Family

Radio/TV

Number of subjects

< 50 years at onset

Neurologist

InternetNurse

Physical/

Occupational/Speech

Friends/Family

Radio/TV

Number of subjects

< 50 years at onset

Sources of Information

P=0.040

Knowledge about Parkinson's and genetics: Number answering correctly (%)

Knowledge Questions:

< 50 years at

onset n (%)

≥ 50 years at onset n (%)

Total (%) p-value

Parkinson's Disease Knowledge Questions:

Parkinson’s disease is less common in people who smoke. 16 (35%) 10 (20%) 27% p = 0.090

Parkinson’s disease always begins after age 50. 45 (98%) 46 (90%) 94% p = 0.120

Parkinson’s disease is caused by a problem in brain cells that use dopamine. 44 (96%) 44 (86%) 91% p = 0.110

There is a gene therapy treatment that can cure Parkinson’s disease. 45 (98%) 47 (92%) 95% p = 0.210

There is an over-the counter, “natural” treatment that can cure Parkinson’s disease. 46 (100%) 48 (94%) 97% p = 0.090

Specific Genetic Questions:A gene is composed of a group of proteins. 9 (20%) 4 (8%) 13% p = 0.090

Genetic diseases always begin in childhood. 39 (85%) 40 (78%) 81% p = 0.440

It is possible to have an abnormal gene without having symptoms of a disease.

43 (93%)

39 (76%) 85% p = 0.020

The Genetics of Parkinson's Disease Questions:

Parkinson’s disease can be caused by a mutation in a gene called parkin. 16

(35%) 4 (8%) 21% p < 0.001

Scientists have identified genes that are associated with a higher risk of Parkinson’s disease.

30 (65%)

19 (37%) 51% p = 0.005

There is a gene test that can identify who will get Parkinson’s disease. 9 (20%) 16 (31%) 26% p = 0.180

< 50 years at

onset n (%)

Total (%) p-value

43 (93%)

39 (76%) 85% p = 0.020

(35%) 4 (8%) 21% p < 0.001

30 (65%)

19 (37%) 51% p = 0.005

< 50 years at

onset n (%)

Total (%) p-value

43 (93%)

39 (76%) 85% p = 0.020

(35%) 4 (8%) 21% p < 0.001

30 (65%)

19 (37%) 51% p = 0.005

Attitudes toward Genetic Testing: Number answering "yes" (%)

Questions

< 50 years at onset

n (%)Total

(%) p-value

Diagnostic Genetic Testing: Would you take this test?

100% genetic risk 33 (72%) 44 (86%) 79% p = 0.250

90% genetic risk 33 (72%) 41 (80%) 76% p = 0.250

60% genetic risk 23 (50%) 34 (67%) 59% p = 0.100

Predictive Genetic Testing: Do you think this genetic test should be offered to people without symptoms of Parkinson’s disease?

100% genetic risk 36 (78%) 34 (67%) 72% p = 0.250

90% genetic risk 32 (70%) 25 (49%) 59% p = 0.050

60% genetic risk 26 (57%) 25 (49%) 53% p = 0.500

Prenatal Genetic Testing: Do you think a prenatal genetic test should be offered to pregnant mothers?

100% genetic risk 23 (50%) 17 (33%) 41% p = 0.100

90% genetic risk 23 (50%) 15 (29%) 39% p = 0.050

60% genetic risk 21 (46%) 13 (25%) 35% p = 0.050

Questions

< 50 years at onset

n (%)Total

(%) p-value

100% genetic risk 33 (72%) 44 (86%) 79% p = 0.250

90% genetic risk 33 (72%) 41 (80%) 76% p = 0.250

60% genetic risk 23 (50%) 34 (67%) 59% p = 0.100

100% genetic risk 36 (78%) 34 (67%) 72% p = 0.250

90% genetic risk 32 (70%) 25 (49%) 59% p = 0.050

60% genetic risk 26 (57%) 25 (49%) 53% p = 0.500

100% genetic risk 23 (50%) 17 (33%) 41% p = 0.100

90% genetic risk 23 (50%) 15 (29%) 39% p = 0.050

60% genetic risk 21 (46%) 13 (25%) 35% p = 0.050

Questions

< 50 years at onset

n (%)Total

(%) p-value

100% genetic risk 33 (72%) 44 (86%) 79% p = 0.250

90% genetic risk 33 (72%) 41 (80%) 76% p = 0.250

60% genetic risk 23 (50%) 34 (67%) 59% p = 0.100

100% genetic risk 36 (78%) 34 (67%) 72% p = 0.250

90% genetic risk 32 (70%) 25 (49%) 59% p = 0.050

60% genetic risk 26 (57%) 25 (49%) 53% p = 0.500

100% genetic risk 23 (50%) 17 (33%) 41% p = 0.100

90% genetic risk 23 (50%) 15 (29%) 39% p = 0.050

60% genetic risk 21 (46%) 13 (25%) 35% p = 0.050

Discussion Overall the attitudes expressed towards diagnostic,

predictive, and prenatal genetic testing were positive 1. A majority (≥ 50%) of patients expressed positive attitudes

toward diagnostic genetic testing at all three levels of genetic risk

2. Young-onset patients expressed positive attitudes toward predictive genetic testing slightly more, but not significantly more, than old-onset patients at all three levels of genetic risk

3. Young-onset patients expressed positive attitudes toward prenatal genetic testing significantly more than old-onset at the 90% and 60% levels of genetic risk (p = 0.050 for both tests)

Most commonly used source of information was a neurologist

Young-onset subjects used the internet significantly more than old-onset (p < 0.001)

Young-onset subjects used lay organizations and support groups/conferences significantly more than the old-onset subjects (p < 0.001 for both resources) a majority of the young-onset subjects were interviewed at a

National Parkinson Foundation conference

Young-onset subjects were significantly more knowledgeable about the genetics of Parkinson’s (p < 0.001 and p = 0.005)Number of patients that correctly answered questions in both

the young-onset and, especially, the old-onset groups was low

Discussion

Applications• Educational programmers:

What aspects of Parkinson’s and genetics to focus programs

Where to publish information to best educate the Parkinson’s community about genetic testing

• Pharmaceutical companies:What populations to target for genetic testingAt what levels of genetic risk patients may be interested in

taking genetic tests

Future Work

• Larger subject population through a mailed survey

• Redesign survey to include reasons for accepting or rejecting genetic testing

• Conduct at a conference oriented toward old-onset or both onset groups

Acknowledgements• Dr. Martha Nance• Catherine Wielinski • Ms. Fruen• 2005-06 Research Team

Knowledge and Attitudes Toward Genetic Testing in

Dana Lundberg 2006

Knowledge and Attitudes Toward Genetic Testing in Parkinson’s Disease Dana Lundberg 2006

Documents

Transcript of Knowledge and Attitudes Toward Genetic Testing in Parkinson’s Disease Dana Lundberg 2006